Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Real-World study tests new Parkinson's pump treatment

NCT ID NCT06639620

Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how well a drug called foslevodopa-foscarbidopa works for people with advanced Parkinson's disease in France. About 250 adults whose doctors have already prescribed this drug will be followed for up to 12 months. The goal is to see if the treatment improves their quality of life in real-world settings, not just in a lab.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

250 people

The number who actually took part.

Started

Nov 2024

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants with advanced Parkinson disease treated with Foscarbidopa/ foslevodopa according to label in France

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants with advanced Parkinson disease with motor complications insufficiently controlled by current therapy * Participants eligible for foscarbidopa / foslevodopa according to French label \& regulation. * Treatment initiation decision prior to and independently from study enrolment Exclusion Criteria: * Participants with any contraindication to foscarbidopa / foslevodopa. * Participants with Mini mental state examination (MMSE) score \< 24

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Advanced Parkinson disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Advanced Parkinson disease

Contacts and locations

Locations

  • CH Bretagne Atlantique /ID# 268308

    Vannes, Morbihan, 56000, France

  • CH Haguenau /ID# 266029

    Haguenau, 67500, France

  • CH de Saint-Brieuc, Paimpol et Tréguier /ID# 266927

    Saint-Brieuc, Brittany Region, 22027, France

  • CHRU de NANCY /ID# 266385

    Nancy, 54035, France

  • CHU Amiens-Picardie Site Sud /ID# 266039

    Amiens, Somme, 80054, France

  • CHU Brest /ID# 266405

    Brest, Finistere, 29200, France

  • CHU de Nantes - Hopital Nord Laennec /ID# 266036

    Saint-Herblain, 44800, France

  • CHU de Rouen /ID# 266390

    Rouen, 76031, France

  • Cabinet de Neurologie /ID# 268309

    Versailles, Yvelines, 78000, France

  • Cabinet de Neurologie des Drs Bonnet et Leguy Bonnet /ID# 276582

    St-Malo, Ille-et-Vilaine, 35400, France

  • Centre Hospitalier Emile Durkheim - Site Plateau de la Justice /ID# 267183

    Épinal, Vosges, 88021, France

  • Centre Hospitalier Intercommunal Toulon /ID# 266397

    Toulon, Var, 83000, France

  • Centre Hospitalier Public du Cotentin - Hôpital Pasteur /ID# 265950

    Cherbourg, 50102, France

  • Centre Hospitalier Regional Universitaire de Besancon - Hopital Jean Minjoz /ID# 266853

    Besançon, Doubs, 25000, France

  • Centre Hospitalier Régional Universitaire de Lille - Hôpital Roger Salengro /ID# 265954

    Lille, Hauts-de-France, 59037, France

  • Centre Hospitalier Universitaire Gabriel-Montpied /ID# 267182

    Clermont-Ferrand, Auvergne-Rhône-Alpes, 63000, France

  • Centre Hospitalier Universitaire de Nîmes - Hôpital Universitaire Carémeau /ID# 266375

    Nîmes, Gard, 30029, France

  • Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou /ID# 267665

    Rennes, Ille-et-Vilaine, 35033, France

  • Centre Hospitalier d'Avignon /ID# 266369

    Avignon, Provence-Alpes-Côte d'Azur Region, 84000, France

  • Centre Hospitalier de Bethune /ID# 265994

    Béthune, Hauts-de-France, 62408, France

  • Centre Hospitalier de Saint Malo /ID# 265948

    St-Malo, 35403, France

  • Centre Hospitalier de Valenciennes /ID# 266400

    Valenciennes, 59300, France

  • Centre Hospitalier de la Côte Basque /ID# 266846

    Bayonne, Pyrenees-Atlantiques, 64109, France

  • Centre hospitalier de Brive /ID# 265952

    Brive-la-Gaillarde, 19100, France

  • Chu De Toulouse - Hopital Pierre Paul Ricquet /ID# 266031

    Toulouse, Occitanie, 31059, France

  • Chu de Limoges /Id# 266043

    Limoges, Franche-Comte, 87042, France

  • Clinique Beausoleil /ID# 266920

    Montpellier, Herault, 34070, France

  • Hopitaux Universitaires Henri Mondor - Hopital Henri Mondor /ID# 266034

    Créteil, Paris, 94010, France

  • Hospices Civils De Lyon - Direction Des Affaires Médicales /ID# 266404

    Lyon, Auvergne-Rhône-Alpes, 69002, France

  • Hôpital Fondation Adolphe de Rothschild /ID# 266373

    Paris, 75019, France

  • Hôpital La Timone /ID# 265932

    Marseille, Bouches-du-Rhone, 13885, France

  • Hôpitaux Civils de Colmar - Hôpital Pasteur /ID# 266932

    Colmar, Grand Est, 68024, France

  • Les Hôpitaux Universitaires de Strasbourg - Hôpital de Hautepierre /ID# 266843

    Strasbourg, Alsace, 67200, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.